Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Characterizing gene perturbations in single cells via network divergence analysis.
PMID 41965857 · PMC13249949 · Nature communications · 2026 · 8 claims · 8 setups
scDNS quantifies gene-specific functional perturbations by measuring Jensen-Shannon divergence between condition-specific gene interaction network configurations
-
Full-text index only
Evolution of genomic sequence inhomogeneity at mid-range scales.
PMID 19891785 · PMC2779198 · BMC genomics · 2009 · 7 claims · 3 setups
MRI regions have comparable levels of de novo mutations to control genomic sequences with average base composition.
-
Has reproduction · 48
Bioinformatics Analysis of the Characteristics and Correlation of m6A Methylation in Breast Cancer Progression.
PMID 35655723 · PMC9148239 · Contrast media & molecular imaging · 2022 · 8 claims · 8 setups
Breast cancer samples can be classified into 4 m6A subtypes (quiescent, m6A methylation, protein-binding, mixed) based on Z-score median of Set1 (writer+reader) and Set2 (eraser) gene expression
-
Full-text index only
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis.
PMID 41814002 · PMC12987733 · Nature genetics · 2026 · 7 claims · 6 setups
Trilaciclib reduces chemotherapy-induced expansion of DDR-gene (TP53, PPM1D, CHEK2) clonal hematopoiesis across four randomized clinical trials and diverse chemotherapy regimens
-
Full-text index only
Functional characterisation of the TSC1-TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex.
PMID 18302728 · PMC2291454 · BMC medical genetics · 2008 · 8 claims · 8 setups
Functional assays of TSC1–TSC2 complex activity can distinguish pathogenic TSC2 mutations from rare polymorphisms when multiple variants segregate in one family